![]() Argenx Argenx is a clinical-stage biotechnology company developing a pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. | ||
Founding Date | Founding Date 2016 | Founding Date 2008 |
Type | Type Private | Type Public |
Tags | ||
Locations | Locations San Diego, US HQ | Locations Gent, BE HQ Minato City, JP Breda, NL Genève, CH Boston, US |
Employees | Employees 10 | Employees 1,599 |
Funding | ||
Total funding raised | Total funding raised $ 155m | Total funding raised $ 396.8m |

Argenx is a clinical-stage biotechnology company developing a pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer.
View company